|Last Price$31.94||Day Change (%)-0.09%|
|Open Price$31.91||Day Change ($)-0.03|
|Day Range31.61–32.09||52-Week Range27.51–33.12|
As of Fri 12/19/2014 07:06 PM EST | USD
Progenics Pharmaceuticals PGNX and partner Wyeth WYE announced Thursday that both the Food and Drug Administration and the European Medicines Agency have accepted new drug applications for subcutaneous MNTX, which aims to treat postoperative ileus and opioid bowel dysfunction. We are leaving our ...
Roche Names New Genentech R&D Chief
Roche Names New Genentech Chief
Inside Clipper Fund's makeover.
Recent deals have been driven more by tax strategies than therapeutic synergies.
We believe breakups could unlock value for big pharma shareholders.
Two veteran investors discuss the winners and losers of reform and where they're looking for future growth.
Things look grim, but investors who can bear it could benefit.